Dr.Brill+Partner

What Dr.Brill+Partner does

Dr. Brill + Partner GmbH Institut für Hygiene und Mikrobiologie, operating as Dr. Brill Institutes, is a privately-held German specialized testing laboratory and regulatory consulting firm founded in 1995 and headquartered in Hamburg with a second lab in Freiburg through its wholly-owned subsidiary Hydrotox Labor für Ökotoxikologie und Gewässerschutz GmbH. The company provides fee-for-service laboratory testing and regulatory affairs services across multiple hygiene, microbiology, ecotoxicology, and medical device domains, organized under sub-brands including Hydrotox (ecotoxicity/biodegradation), Brill Regulatory Services (IUCLID dossier preparation for biocidal product authorization), BB Applied Hygiene (household hygiene efficacy), Biofilm Services, and Clinical Study Services/Genomics.

The firm's core technology is accredited efficacy testing across an unusually broad set of international standards — DIN EN 14885 for disinfectants, Pharm. Eur. 5.1.3 and USP for preservative challenge tests, ISO 10993 series for medical device biocompatibility, ISO 17664 for reprocessing validation, ISO 22196/21702 for antimicrobial and antiviral surfaces, and multiple ASTM standards for antifouling and biofilm removal. It also offers niche specialized testing including biogenic sulfuric acid corrosion and microbiologically influenced metal corrosion testing. The regulatory affairs team provides IUCLID dossier preparation and updates for biocidal active substance authorizations under the EU Biocidal Products Regulation.

Revenue is generated through project-based, quote-driven professional services engagements with enterprise clients in biocidal product manufacturing, medical device manufacturing, industrial manufacturing, antifouling coatings, household hygiene products, and environmental compliance. The go-to-market is sales-led B2B, with direct outreach, industry events, regulatory thought leadership, and a German/English corporate website. Customer relationships are anchored by recurring regulatory-driven work such as dossier renewals and IUCLID format updates. No public pricing, revenue, or ownership structure details are disclosed.

Name

Dr.Brill+Partner

Legal name

Dr. Brill + Partner GmbH Institut für Hygiene und Mikrobiologie

Website

https://brillhygiene.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

51–100 employees

Short description

Dr. Brill + Partner is a German accredited testing laboratory and regulatory consulting firm providing efficacy validation, biocompatibility testing, ecotoxicology, biocidal product authorization (IUCLID dossiers), and biofilm/biocorrosion testing under international DIN, ISO, ASTM, USP, and Pharm. Eur. standards for enterprise clients in biocidal, medical device, industrial, and household hygiene sectors.

Ownership category

akta.pro rank

Product category

Hygiene and Microbiology Testing Services

NAICS

Testing Laboratories and Services (54138), Testing Laboratories and Services (541380), Environmental Consulting Services (541620)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYAFALADAA

Regulatory Compliance Testing (Microbiological, Chemical, Allergen)

Agriculture & Food Production/Food Safety, Testing & Certification/Regulatory Compliance Testing & Consulting (FDA/USDA/EFSA, HACCP)

SECONDARYAFALAAAD

Regulatory Compliance & HACCP Consulting (FDA/USDA/EFSA)

Agriculture & Food Production/Food Safety, Testing & Certification/Food Testing Laboratories (Microbiological, Chemical, Allergen)

SECONDARYHLAJAIAG

Environmental Public Health Laboratories (Water/Air/Soil)

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

Keywords

• Laboratory testing services
• Biocidal efficacy testing
• Medical device validation
• Ecotoxicology testing
• Regulatory affairs consulting

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Laboratory Testing Services: Fee-for-service laboratory testing providing efficacy validation for disinfectants, biocides, medical devices, antifouling products, and household hygiene products. Services are project-based with quotes provided per testing requirement.
2. Regulatory Consulting Services: Expert regulatory affairs consulting for biocidal product authorization, IUCLID dossier preparation, and compliance with ECHA requirements. Includes dossier updates and renewal application support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Dr. Brill+Partner is a German hygiene and microbiology testing institute that provides accredited laboratory testing services to validate the efficacy and regulatory compliance of disinfectants, biocidal products, medical devices, antifouling products, household hygiene products, and biofilm-related materials, alongside regulatory affairs consulting for EU BPR and ECHA authorization. Testing is delivered from laboratories in Hamburg and Freiburg (via the Hydrotox subsidiary for ecotoxicology and water protection) under recognized international standards including DIN EN 14885, ISO 10993, ISO 17664, ASTM, Pharm. Eur., and USP.

Product overview

Dr. Brill Institutes operates as a multi-service institute focused on hygiene and microbiology testing. The portfolio includes specialized sub-brands and service offerings: Hydrotox for ecotoxicity and biodegradation testing, Brill Regulatory for regulatory affairs and IUCLID dossier preparation, and Applied Hygiene for household hygiene testing. Core service offerings cover biocorrosion and material testing, medical device hygiene and biocompatibility, antifouling efficacy, clinical study services, biocide product efficacy, and biofilm services. Testing capabilities include disinfectant efficacy per DIN EN 14885, preservative challenge tests per Pharm. Eur. 5.1.3 and USP, antimicrobial and antiviral surface testing per ISO 22196, ISO 21702, ISO 20743, and ISO 18846.

Differentiator

Problem solved

Functional benefit

Brands

• Dr. Brill Regulatory Services: Regulatory affairs services for biocidal products compliance
• Hydrotox
• BB Applied Hygiene
• Biofilm Services
• Clinical Study Services

Products and services

• Ecotoxicity and Biodegradation Testing (Hydrotox) Ecotoxicology and biodegradation testing services delivered by the Hydrotox subsidiary in Freiburg for companies requiring environmental risk assessment, aquatic toxicity evaluation, and biodegradation confirmation for chemical and consumer product registration.
• Regulatory Affairs Services for Biocidal Products Regulatory affairs consulting for biocidal product manufacturers, including preparation and updating of authorization dossiers for the EU Biocidal Products Regulation (BPR) and ECHA IUCLID format compliance for active substance approval renewals.
• Biocorrosion and Material Testing Material testing for resistance against biogenic sulfuric acid corrosion and microbiologically influenced metal corrosion, serving industrial clients needing equipment degradation and failure prevention assessments.
• Medical Device Hygiene and Biocompatibility Testing Hygiene, biocompatibility, and reprocessing validation testing for medical device manufacturers, including in-vitro cytotoxicity per ISO 10993-5 and ISO 10993-23, antimicrobial and antiviral surface testing per ISO 22196, ISO 21702, ISO 20743, ISO 18846, and validation of medical device reprocessing per ISO 17664-1 and -2.
• Antifouling Product Efficacy Testing Laboratory efficacy testing of antifouling coatings and marine treatment products in accordance with ASTM D3623-78a and ASTM D6990-20, serving manufacturers requiring specification-level validation.
• Clinical Study Services and Genomics Clinical study services supporting genomics research and laboratory testing activities, delivered through the Clinical Study Services sub-brand under Dr. Brill Institutes.
• Biocidal Product Efficacy Testing Laboratory efficacy testing of biocidal products including disinfectant efficacy testing per DIN EN 14885 and preservation challenge testing per Pharm. Eur. 5.1.3, USP, and ISO 11930, paired with dossier preparation for BPR authorization.
• Household Hygiene Product Efficacy Testing (BB Applied Hygiene) Efficacy testing of household cleaning and hygiene products per EN 17658, supporting claim substantiation and regulatory compliance for consumer hygiene product launches.
• Biofilm Services Biofilm removal efficacy testing using standardized methods including ASTM E2532 (CDC Reactor), ASTM 2799-12 (MBEC), and ISO 85583-5 for flexible endoscopes, plus biofilm resistance testing for autoclave air conditioning systems and Stürmer et al. wound applications.

Quantifiable outcome

• New ERP system implementation in July 2026 expected to deliver faster processing times, improved data quality, and enhanced traceability
• +1 more outcomes

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

One partnership is on record.

• ECHA (European Chemicals Agency)coreOthersCompany works in compliance with ECHA requirements for biocidal product authorization. Services include IUCLID dossier preparation and updates for biozid Wirkstoff (biocidal active substance) authorization and renewal applications. ECHA mandate IUCLID format for all extension applications starting July 1, 2026.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• SGS: Global testing, inspection, and certification company with a German presence providing laboratory services including disinfectant efficacy, medical device testing, and ecotoxicology. Operates across a much wider service portfolio than Dr. Brill+Partner but overlaps on hygiene and regulatory testing.
• Eurofins Scientific: Global leader in bioanalytical testing with a strong German footprint (Eurofins BioPharma Product Testing in Hamburg area). Offers overlapping capabilities in disinfectant efficacy, antimicrobial surface testing, medical device biocompatibility, and ecotoxicology, but as part of a much broader portfolio across food, pharma, and environmental testing.
• TÜV Rheinland: German-headquartered TIC services provider with laboratory testing for medical devices, chemicals, and hygiene-related products. Comparable to Dr. Brill+Partner on medical device hygiene/biocompatibility testing and chemical compliance services, though at much larger scale and broader scope.
• Intertek: Global testing and certification group offering chemical, microbiological, and medical device testing with European laboratory footprint. Overlaps with Dr. Brill+Partner in antimicrobial efficacy, medical device biocompatibility, and regulatory-driven testing services.
• Bureau Veritas: International TIC provider with hygiene, microbiological, and biocidal product testing capabilities across European markets. Comparable to Dr. Brill+Partner on regulatory compliance testing for chemical and biocidal products, though delivered as part of a broader industry certification portfolio.
• Charles River Laboratories: Global contract research organization with laboratory testing services for pharmaceutical, medical device, and chemical clients. Overlaps with Dr. Brill+Partner on medical device biocompatibility, microbiological testing, and regulatory-support services, though with much broader life-sciences scope.
• TÜV SÜD: German testing and certification organization with laboratory services spanning medical device testing, chemical compliance, and environmental analysis. Overlaps with Dr. Brill+Partner on medical device validation, biocompatibility testing, and regulatory-driven chemical testing.

Direct peers

• Smithers: Specialized testing, consulting, and contract research provider for medical devices, pharmaceuticals, and industrial materials. Directly comparable to Dr. Brill+Partner on antimicrobial/efficacy testing, biocompatibility, and regulatory-affiliated laboratory services, though US-headquartered.
• BSL Bioservice Scientific Laboratories: Munich-based contract laboratory offering biosafety, microbiological, and biocompatibility testing for medical devices, pharmaceuticals, and chemical products. Closely comparable niche positioning to Dr. Brill+Partner's medical device hygiene and microbiological efficacy testing services.
• IUF – Leibniz-Institut für umweltmedizinische Forschung: German research institute focused on environmental medicine and toxicology with testing capabilities relevant to ecotoxicology and hygiene-related evaluation. Comparable niche to Dr. Brill+Partner's Hydrotox subsidiary, though with a research rather than commercial-service orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/dr_partner

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr.Brill+Partner